AHCO
AdaptHealth Corp.
NASDAQ · Healthcare · Medical - Devices · US
$6.46
+0.62%Year over year
Reported trailing growth
- Revenue
- +14.6%
- EBITDA
- -53.5%
- EBIT
- —
- EPS
- —
- Free cash flow
- -57.8%
- Operating cash flow
- +5.6%
Forward estimates
Based on analyst estimates
- Revenue
- -1.9%
- EBITDA
- +90.3%
- EPS
- +95.0%
Three-year CAGR
- Revenue
- +3.0%
- EBITDA
- -7.2%
- EBIT
- -0.7%
- Net income
- —
- EPS
- —
- Free cash flow
- +23.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026